Skip to content

A bedside evaluation of a marker of heart injury in the blood

The second bedside evaluation of sensitive troponin (BEST-2) Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN48377837
Enrollment
700
Registered
2022-07-08
Start date
2022-07-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndromes Circulatory System

Interventions

An additional blood sample will be taken at the same time as routine sampling for the majority of patients. Some patients may require blood to be drawn after they have had routine blood samples. To mi

Sponsors

Manchester University NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or more 2. Presenting to the emergency department with a primary complaint of pain or discomfort in the chest, epigastrium, arm(s), jaw, neck or throat, which the treating clinician suspects may have been caused by an acute coronary syndrome

Exclusion criteria

Exclusion criteria: 1. Overt ST-elevation myocardial infarction (STEMI) requiring immediate referral for coronary revascularization 2. Another reason requiring hospital admission, even if the diagnosis of acute coronary syndrome is excluded (e.g. arrhythmia, gastrointestinal bleeding, sepsis) 3. No symptoms in the previous 12 hours 4. No capacity, or unwillingness, to provide written informed consent

Design outcomes

Primary

MeasureTime frame
Diagnostic accuracy of the Siemens Atellica VTLi high-sensitivity cardiac troponin I assay, measured on arrival in the emergency department and 1 hour later using thresholds below the 99th percentile upper reference limit, for the target condition of acute myocardial infarction

Secondary

MeasureTime frame
1. Incidence of major adverse cardiac events (MACE, cardiovascular death or AMI occurring within 30 days of enrolment), as measured by a review of medical records and/or GP questionnaire at 30 days 2. Incidence of coronary revascularization, as measured by review of medical records and/or GP questionnaire at 30 days 3. All-cause mortality, as measured by review of medical records and/or GP questionnaire at 30 days 4. Length of hospital stay, as measured by review of medical records and/or GP questionnaire at 30 days

Countries

England, United Kingdom

Contacts

Public ContactRichard Body
best.2study@mft.nhs.uk+44 (0)161 276 6777

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026